Obesity drugs may be sold at just $149 a month, get covered under Medicare under a reported White House deal in the works
Up next
Author


The White House is close to announcing a deal with drugmakers Eli Lilly and Novo Nordisk that would cut the price of obesity drugs to $149 per month in some cases and extend coverage to certain Medicare and Medicaid beneficiaries, according to media reports Tuesday.

You May Also Like

Treasury yields rangebound as market stays muted ahead of inflation data

Bond yields were little changed early Wednesday, with traders again wary of…
Rakuten shares gain in Tokyo after strong outlook

Rakuten shares gain in Tokyo after strong outlook

Shares of Rakuten Group JP:4755 rose sharply after its results showed a…
Mexico’s unbanked population ‘now big enough to count’ for fintech companies

Mexico’s unbanked population ‘now big enough to count’ for fintech companies

An underbanked and heavily cash-based economy offers fertile ground for a trio…
Palo Alto Networks' stock falls despite ‘unprecedented’ cybersecurity attacks

Palo Alto Networks’ stock falls despite ‘unprecedented’ cybersecurity attacks

Shares of Palo Alto Networks Inc. slid after hours Wednesday after the…